Meta-analytical federated surveillance for incubation period with interval- and right-censored data with stochastic variational inference
Biometrics · 2026
DOI: 10.1093/biomtc/ujag172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrics, 2026. Verfasst von Daisuke Yoneoka und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, 1628640, Japan. Hauptthemen laut MEDLINE: COVID-19, Meta-Analysis as Topic. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science Technology Agency, JSPS.
Abstract (Originalsprache)
Accurate estimation of incubation period is fundamental to surveillance for infectious diseases. This task faces two major challenges: (1) surveillance data are often coarsely observed, comprising interval- and right-censored observations, and (2) patient-level data are frequently fragmented across multiple facilities and cannot be pooled due to privacy constraints. While traditional meta-analysis (MA) aggregates summary statistics, its one-shot nature limits the ability to fit complex hierarchical models. We propose a novel federated Bayesian framework, Federated Stochastic Variational Inference (Fed-SVI), which extends the summary-statistic philosophy of MA into an iterative, model-based federated approach. Our method fits a hierarchical lognormal model, explicitly modeling heterogeneity while estimating a global distribution. To fit this model privately, Fed-SVI iteratively exchanges summary statistics (local variational parameters). Each facility analytically computes these local parameters, rigorously incorporating the likelihood contributions of coarsely-observed data via expectations of the truncated normal distribution. A central server aggregates these parameters using stochastic natural-gradient ascent, enabling efficient information borrowing and mini-batch updates. Through extensive simulations, we demonstrate that Fed-SVI achieves accuracy nearly identical to a fully centralized analysis, while substantially outperforming naive federated or MA methods that discard censored information. We apply Fed-SVI to a distributed COVID-19 line list from 177 facilities, yielding results consistent with centralized estimates. Fed-SVI provides a scalable, accurate, and privacy-preserving solution for robust surveillance in modern data networks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, 1628640, Japan.
- Graduate School of Medicine, The University of Tokyo, Tokyo, 1130033, Japan.
- Department of Mathematical and Computing Science, Institute of Science Tokyo, Tokyo, 1528552, Japan.
- Faculty of Marine Technology, Tokyo University of Marine Science and Technology, Tokyo, 1358533, Japan.
- Global Health Policy Lab, International Research Institute of Disaster Science, Tohoku University, Sendai, 9808572, Japan.
- Global Health Policy Lab, Graduate School of Medicine, Tohoku University, Sendai, 9808575, Japan.
ORCID-Profile: Daisuke Yoneoka
Förderung
- Japan Science Technology Agency
- JSPS
Zitieren
APA
Yoneoka, D., Kawashima, T., Tanoue, Y., Nomura, S., & Eguchi, A. (2026). Meta-analytical federated surveillance for incubation period with interval- and right-censored data with stochastic variational inference. Biometrics. https://doi.org/10.1093/biomtc/ujag172
Vancouver
Yoneoka D, Kawashima T, Tanoue Y, Nomura S, Eguchi A. Meta-analytical federated surveillance for incubation period with interval- and right-censored data with stochastic variational inference. Biometrics. 2026. doi:10.1093/biomtc/ujag172
BibTeX
@article{Yoneoka2026,
author = {Yoneoka, Daisuke and Kawashima, Takayuki and Tanoue, Yuta and Nomura, Shuhei and Eguchi, Akifumi},
title = {Meta-analytical federated surveillance for incubation period with interval- and right-censored data with stochastic variational inference},
journal = {Biometrics},
year = {2026},
doi = {10.1093/biomtc/ujag172}
}
EUVIMED